Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993168priorityCriticalpatent/ECSP993168A/en
Publication of ECSP993168ApublicationCriticalpatent/ECSP993168A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a una composición farmacéutica útil para el tratamiento de la rinitiis alérgica, el asma y trastornos relacionados. En una realización, la composición comprende, en combinación, una cantidad terapéuticamente efectiva de al menos un de neuroquinina, una cantidad efectiva de al menos un antagonista H3 y una cantidad efectiva de al menos un antagonista H1.The present invention relates to a pharmaceutical composition useful for the treatment of allergic rhinitis, asthma, and related disorders. In one embodiment, the composition comprises, in combination, a therapeutically effective amount of at least one neuroquinine, an effective amount of at least one H3 antagonist, and an effective amount of at least one H1 antagonist.
ECSP9931681999-10-061999-10-06
COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES
ECSP993168A
(en)
Compound, pharmaceutical composition, methods for treating prostaglandin d2 mediated diseases, for treating nasal congestion, for treating allergic asthma, and for treating allergic rhinitis, pharmaceutically acceptable salt, and use of a compound or salt
Compound, pharmaceutical composition, methods for treating prostaglandin-mediated diseases, nasal congestion, allergic asthma, and allergic rhinitis, and use of a compound
COMPOUNDS DERIVED FROM DIAMINOTRIAZOLS, INHIBITORS D ELA PROTEINA QUINASA; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE; AND ITS USE OF THE COMPOUND IN THE TREATMENT OF DISEASES OF ALLERGIC DISORDERS, PROLIFERATION, AUTOIMMUNES, CONDIC
compounds, process for the manufacture thereof, pharmaceutical compositions comprising them, method for treating and / or prophylaxis of diseases that are associated with cb1 receptor modulation and their use
compound, method for treating, preventing or ameliorating obesity and related diseases and / or symptoms thereof, pharmaceutical composition, compound use, and combination
Compound, pharmaceutical composition, method of treating or preventing disease, method for enhancing cognition in a healthy patient, and use of a compound
Pharmaceutical composition, use of a pharmaceutical compound, method for treating disorders, pharmaceutical compound and method for making a pharmaceutical compound